Bleichroeder LP’s Royalty Pharma RPRX Stock Holding History

Bleichroeder LP’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-824,033	Closed	-$32.8M	–	116
2021 Q4	$32.8M	Sell	824,033 -291,947	-26%	-$11.3M	5.13%	5
2021 Q3	$40.3M	Buy	1,115,980 +915,980	+458%	+$35.6M	6.55%	5
2021 Q2	$8.2M	Hold	200,000	–	–	1.24%	23
2021 Q1	$8.72M	Hold	200,000	–	–	1.47%	20
2020 Q4	$10M	Sell	200,000 -915,980	-82%	-$38.9M	1.95%	15
2020 Q3	$46.9M	Hold	1,115,980	–	–	8.4%	2
2020 Q2	$54.2M	Buy	+1,115,980	New	+$55.2M	9.58%	3

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SGA

Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP's RPRX Position: Q1 2022 in Review

Bleichroeder LP sold out of Royalty Pharma (RPRX) in Q1 2022, closing a stake of 824,033 shares — an estimated $32.8M sold.

Bleichroeder LP first reported a position in RPRX in Q2 2020 and held it in 7 quarters. The position peaked at $54.2M in Q2 2020. 279 funds tracked by Wall St. Rank hold RPRX as of Q1 2022.

Bleichroeder LP reported no remaining Royalty Pharma position as of Q1 2022 after selling out during the quarter.
Bleichroeder LP sold 824,033 Royalty Pharma shares in Q1 2022, an estimated $32.8M.
Bleichroeder LP first reported a position in Royalty Pharma in Q2 2020 and held it in 7 quarters.
Bleichroeder LP's Royalty Pharma position peaked at $54.2M in Q2 2020.
279 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2022.

Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.